Klebl BM - Search Results

1

Host cell targets in HCV therapy: novel strategy or proven practice?

Klebl BM, Kurtenbach A, Salassidis K, Daub H, Herget T. Klebl BM, et al. Antivir Chem Chemother. 2005;16(2):69-90. doi: 10.1177/095632020501600201. Antivir Chem Chemother. 2005. PMID: 15889531 Free article. Review.

2

Cellular targets of gefitinib.

Brehmer D, Greff Z, Godl K, Blencke S, Kurtenbach A, Weber M, Müller S, Klebl B, Cotten M, Kéri G, Wissing J, Daub H. Brehmer D, et al. Cancer Res. 2005 Jan 15;65(2):379-82. Cancer Res. 2005. PMID: 15695376

3

Interplay between mycobacteria and host signalling pathways.

Koul A, Herget T, Klebl B, Ullrich A. Koul A, et al. Nat Rev Microbiol. 2004 Mar;2(3):189-202. doi: 10.1038/nrmicro840. Nat Rev Microbiol. 2004. PMID: 15083155 Review. No abstract available.

4

Evaluation of kinase inhibitor selectivity by chemical proteomics.

Daub H, Godl K, Brehmer D, Klebl B, Müller G. Daub H, et al. Assay Drug Dev Technol. 2004 Apr;2(2):215-24. doi: 10.1089/154065804323056558. Assay Drug Dev Technol. 2004. PMID: 15165517 Review.

5

Advances in anti-viral therapeutics.

Klebl BM. Klebl BM. Expert Opin Investig Drugs. 2005 Mar;14(3):343-8. doi: 10.1517/13543784.14.3.343. Expert Opin Investig Drugs. 2005. PMID: 15833066

6

RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response.

Eickhoff J, Hanke M, Stein-Gerlach M, Kiang TP, Herzberger K, Habenberger P, Müller S, Klebl B, Marschall M, Stamminger T, Cotten M. Eickhoff J, et al. J Biol Chem. 2004 Mar 5;279(10):9642-52. doi: 10.1074/jbc.M312893200. Epub 2003 Dec 10. J Biol Chem. 2004. PMID: 14670961 Free article.

7

Second-generation kinase inhibitors.

Klebl BM, Müller G. Klebl BM, et al. Expert Opin Ther Targets. 2005 Oct;9(5):975-93. doi: 10.1517/14728222.9.5.975. Expert Opin Ther Targets. 2005. PMID: 16185153 Review.

8

Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo.

Schleiss M, Eickhoff J, Auerochs S, Leis M, Abele S, Rechter S, Choi Y, Anderson J, Scott G, Rawlinson W, Michel D, Ensminger S, Klebl B, Stamminger T, Marschall M. Schleiss M, et al. Antiviral Res. 2008 Jul;79(1):49-61. doi: 10.1016/j.antiviral.2008.01.154. Epub 2008 Feb 22. Antiviral Res. 2008. PMID: 18329738

9

Chemical kinomics - a target gene family approach in chemical biology.

Klebl BM. Klebl BM. Drug Discov Today Technol. 2004 Sep;1(1):25-34. doi: 10.1016/j.ddtec.2004.08.013. Drug Discov Today Technol. 2004. PMID: 24981264

10

The tyrosine kinase inhibitor STI571 induces cellular clearance of PrPSc in prion-infected cells.

Ertmer A, Gilch S, Yun SW, Flechsig E, Klebl B, Stein-Gerlach M, Klein MA, Schätzl HM. Ertmer A, et al. J Biol Chem. 2004 Oct 1;279(40):41918-27. doi: 10.1074/jbc.M405652200. Epub 2004 Jul 9. J Biol Chem. 2004. PMID: 15247213 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page